SCHEMBL24169366

SCHEMBL24169366

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc5c(c4)c4ccccc4c4ccc(-c6ccc7sc8ccccc8c7c6)cc45)cc3)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM3 Q86V86 2/20 0.44
GPR3 P46089 1/20 0.42
LIMK1 P53667 2/20 0.42
CYP1A2 P05177 1/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 2/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ROCK1 Q13464 1/20 0.40
F9 P00740 2/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
PIK3CA P42336 1/20 0.39
PI4KA P42356 1/20 0.39
PI4KB Q9UBF8 1/20 0.39
ATM Q13315 1/20 0.38
PIM1 P11309 1/20 0.37
PIM2 Q9P1W9 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15501789 1.00 PIM3 (0.44) PIM3GPR3LIMK1CYP1A2ALDH1A1
SCHEMBL24169783 1.00 PIM3 (0.44) PIM3GPR3LIMK1CYP1A2ALDH1A1
SCHEMBL24169815 0.98 PIM3 (0.43) PIM3GPR3LIMK1CYP1A2ALDH1A1
SCHEMBL24169547 0.98 PIM3 (0.43) PIM3GPR3LIMK1CYP1A2ALDH1A1
SCHEMBL24169629 0.98 PIM3 (0.43) PIM3GPR3LIMK1CYP1A2ALDH1A1
SCHEMBL24169294 0.98 PIM3 (0.43) PIM3GPR3LIMK1CYP1A2ALDH1A1
SCHEMBL24169841 0.97 GPR3 (0.42) PIM3GPR3LIMK1CYP1A2ALDH1A1
SCHEMBL24169330 0.97 GPR3 (0.42) PIM3GPR3LIMK1CYP1A2ALDH1A1
SCHEMBL18960978 0.97 GPR3 (0.42) PIM3GPR3LIMK1CYP1A2ALDH1A1
SCHEMBL22240685 0.95 PIM3 (0.43) PIM3GPR3LIMK1CYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337526-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO.,LTD. (KR) 2023-10-19 US disclosed
US-20230337526-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO.,LTD. (KR) 2023-10-19 US disclosed
EP-4174060-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-05-03 EP disclosed
WO-2021261849-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 엘티소재주식회사 2021-12-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337526-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1B1, LEF1 PIM3 3114/4885GPR3 2599/4885LIMK1 100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.